CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.27%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.8B
AUM Growth
-$159M
(-3.2%)
Cap. Flow
-$221M
Cap. Flow
% of AUM
-4.61%
Top 10 Holdings %
Top 10 Hldgs %
18.32%
Holding
699
New
64
Increased
242
Reduced
263
Closed
62
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$33.5M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$32.3M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$30.8M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$29.8M |
| 5 |
GAP
The Gap, Inc.
GAP
|
+$25M |
Top Sells
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$40.8M |
| 2 |
Intuit
INTU
|
+$32.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.9M |
| 4 |
Mastercard
MA
|
+$28.9M |
| 5 |
Nike
NKE
|
+$27.3M |
Sector Composition
| 1 | Healthcare | 29.43% |
| 2 | Financials | 13.37% |
| 3 | Technology | 9.88% |
| 4 | Consumer Discretionary | 7.77% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Altria Group
MO
$110B
| $5.33M | 0.11% |
109,020
-64,437
| -37% | -$3.15M |
|
|
CLVS
227
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.27M | 0.11% |
60,000
-10,000
| -14% | -$879K |
|
|
SAGE
228
DELISTED
Sage Therapeutics
SAGE
| $5.26M | 0.11% |
72,000
-7,000
| -9% | -$511K |
|
|
AKRX
229
DELISTED
Akorn, Inc.
AKRX
| $5.15M | 0.11% |
118,000
+93,000
| +372% | +$4.06M |
|
230
VanEck Gold Miners ETF
GDX
$20.1B
| $5.15M | 0.11% |
+290,000
| New | +$5.15M |
|
231
TechnipFMC
FTI
$16.3B
| $5.12M | 0.11% |
165,726
+40,106
| +32% | +$1.24M |
|
|
GHDX
232
DELISTED
Genomic Health, Inc.
GHDX
| $5.11M | 0.11% |
184,000
+73,000
| +66% | +$2.03M |
|
233
MacroGenics
MGNX
$107M
| $5.09M | 0.11% |
134,000
-91,000
| -40% | -$3.46M |
|
234
Neurocrine Biosciences
NBIX
$14.1B
| $5.02M | 0.1% |
105,000
-50,000
| -32% | -$2.39M |
|
235
TG Therapeutics
TGTX
$5.05B
| $4.98M | 0.1% |
300,000
-30,000
| -9% | -$498K |
|
236
Manulife Financial
MFC
$52.5B
| $4.97M | 0.1% |
267,169
-473,220
| -64% | -$8.8M |
|
|
OMG
237
DELISTED
OM GROUP INC.
OMG
| $4.96M | 0.1% |
+147,725
| New | +$4.96M |
|
|
KYTH
238
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $4.86M | 0.1% |
+64,476
| New | +$4.86M |
|
239
Kohl's
KSS
$1.81B
| $4.81M | 0.1% |
76,753
-221,699
| -74% | -$13.9M |
|
240
Paychex
PAYX
$48.3B
| $4.76M | 0.1% |
101,488
-186,523
| -65% | -$8.74M |
|
241
Bank of New York Mellon
BK
$74.1B
| $4.74M | 0.1% |
113,044
+95,790
| +555% | +$4.02M |
|
|
HCC
242
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $4.71M | 0.1% |
+61,264
| New | +$4.71M |
|
243
Devon Energy
DVN
$22.1B
| $4.66M | 0.1% |
78,326
-1,956
| -2% | -$116K |
|
244
Ionis Pharmaceuticals
IONS
$10.1B
| $4.6M | 0.1% |
80,000
-20,000
| -20% | -$1.15M |
|
245
Goldman Sachs
GS
$229B
| $4.56M | 0.09% |
21,843
-1,112
| -5% | -$232K |
|
|
TSRO
246
DELISTED
TESARO, Inc.
TSRO
| $4.53M | 0.09% |
77,000
-63,000
| -45% | -$3.7M |
|
247
McKesson
MCK
$87.2B
| $4.48M | 0.09% |
19,918
-2,215
| -10% | -$498K |
|
|
ISEE
248
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.43M | 0.09% |
85,000
-51,000
| -38% | -$2.66M |
|
|
AGEN
249
Agenus
AGEN
$145M
| $4.4M | 0.09% |
25,985
-5,604
| -18% | -$949K |
|
|
KITE
250
DELISTED
Kite Pharma, Inc.
KITE
| $4.39M | 0.09% |
72,000
-8,000
| -10% | -$488K |
|